Overview Fundamentals API Earnings EOD API Sample Code Pricing

Equillium Inc (EQ NASDAQ) stock market data APIs

$0.7515 -0.09(-10.7%) as of July 12, 2024
Price chart is built with Anychart

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a first-in-class monoclonal antibody that targets the immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase I clinical trial for the treatment of ulcerative colitis; and Phase I clinical trial for the treatment of lupus nephritis. It also develops EQ101 completed phase 1/2 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ302 to treat gastrointestinal indications. In addition, it serves dermatology, gastroenterology, rheumatology, hematology, transplant science, oncology, and pulmonology area. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.

Equillium Inc Financial Data Overview

0.8423
0.7515
-
0.8423
0.7405
0.45-3.25
29 695 K
35 255 K
37 894 K
-0.08
1.818
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'EQ',
Type: 'Common Stock',
Name: 'Equillium Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00LSL8C10',
ISIN: NULL,
CUSIP: NULL,
CIK: '1746466',
EmployerIdNumber: '20-3828755',
FiscalYearEnd: 'December',
IPODate: '2018-10-11',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Equillium Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 37 894 K
  • EBITDA -13 078 000
  • Earnings Per Share -0.35
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Equillium Inc Earnings via APIs

  • Latest Release 2024-05-09
  • EPS/Forecast -0.15

Get Equillium Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com